Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Impaired work ability, Product dose omission issue
Clinical narrative: dizzy; shortness of breath; slurred speech; medication they gave him to counter the low blood pressure burned his toes and fingers; Blood pressure low; first dose > 25 days ago; couldn't go to work/obviously  can't work; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), DYSPNOEA (shortness of breath), DYSARTHRIA (slurred speech), ADVERSE DRUG REACTION (medication they gave him to counter the low blood pressure burned his toes and fingers) and HYPOTENSION (Blood pressure low) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced DYSPNOEA (shortness of breath) (seriousness criteria hospitalization prolonged and disability), DYSARTHRIA (slurred speech) (seriousness criteria hospitalization prolonged and disability) and IMPAIRED WORK ABILITY (couldn't go to work/obviously  can't work). On 16-Mar-2021, the patient experienced DIZZINESS (dizzy) (seriousness criteria hospitalization prolonged and disability). In 2021, the patient experienced ADVERSE DRUG REACTION (medication they gave him to counter the low blood pressure burned his toes and fingers) (seriousness criteria hospitalization prolonged and disability). On an unknown date, the patient experienced HYPOTENSION (Blood pressure low) (seriousness criterion medically significant) and PRODUCT DOSE OMISSION ISSUE (first dose > 25 days ago). At the time of the report, DIZZINESS (dizzy), DYSPNOEA (shortness of breath), DYSARTHRIA (slurred speech), ADVERSE DRUG REACTION (medication they gave him to counter the low blood pressure burned his toes and fingers), HYPOTENSION (Blood pressure low) and IMPAIRED WORK ABILITY (couldn't go to work/obviously  can't work) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (first dose > 25 days ago) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: low (Low) blood pressure was lowered to the point where he almost died.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient states he is trying to deal with the injury compensation program.he remained in hospital for 5 months. His blood pressure was lowered to the point where he almost died. They amputated both of his feet and the all fingers on his right hand because the medication they gave him to counter the low blood pressure burned his toes and fingers. He states there was a similar case from a lady. She had both hands and feet amputated. He states he was fully healthy before he got the shot. Obviously now he can't work.  No concomitant medications were reported.  No treatment information was provided.  Company comment: This case concerns Product dose omission issue in a 67 year-old male patient with no reported medical history, who experienced the unexpected serious events of Dizziness, Dyspnoea, Dysarthria, Hypotension, and Adverse drug reaction. The event of Dizziness occurred on the same day as the first dose of mRNA-1273 vaccine, and the other events occurred an unknown number of days after the first dose. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns Product dose omission issue in a 67 year-old male patient with no reported medical history, who experienced the unexpected serious events of Dizziness, Dyspnoea, Dysarthria, Hypotension, and Adverse drug reaction. The event of Dizziness occurred on the same day as the first dose of mRNA-1273 vaccine, and the other events occurred an unknown number of days after the first dose. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.